731 related articles for article (PubMed ID: 23769949)
1. Molecular mechanisms and signaling pathways of angiotensin II-induced muscle wasting: potential therapeutic targets for cardiac cachexia.
Yoshida T; Tabony AM; Galvez S; Mitch WE; Higashi Y; Sukhanov S; Delafontaine P
Int J Biochem Cell Biol; 2013 Oct; 45(10):2322-32. PubMed ID: 23769949
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of Cachexia in Chronic Disease States.
Yoshida T; Delafontaine P
Am J Med Sci; 2015 Oct; 350(4):250-6. PubMed ID: 26083652
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II reduces food intake by altering orexigenic neuropeptide expression in the mouse hypothalamus.
Yoshida T; Semprun-Prieto L; Wainford RD; Sukhanov S; Kapusta DR; Delafontaine P
Endocrinology; 2012 Mar; 153(3):1411-20. PubMed ID: 22234465
[TBL] [Abstract][Full Text] [Related]
4. THE RENIN-ANGIOTENSIN SYSTEM AND THE BIOLOGY OF SKELETAL MUSCLE: MECHANISMS OF MUSCLE WASTING IN CHRONIC DISEASE STATES.
Delafontaine P; Yoshida T
Trans Am Clin Climatol Assoc; 2016; 127():245-258. PubMed ID: 28066057
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II upregulates protein phosphatase 2Cα and inhibits AMP-activated protein kinase signaling and energy balance leading to skeletal muscle wasting.
Tabony AM; Yoshida T; Galvez S; Higashi Y; Sukhanov S; Chandrasekar B; Mitch WE; Delafontaine P
Hypertension; 2011 Oct; 58(4):643-9. PubMed ID: 21844485
[TBL] [Abstract][Full Text] [Related]
6. Muscle wasting in cancer.
Johns N; Stephens NA; Fearon KC
Int J Biochem Cell Biol; 2013 Oct; 45(10):2215-29. PubMed ID: 23770121
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II: role in skeletal muscle atrophy.
Cabello-Verrugio C; Córdova G; Salas JD
Curr Protein Pept Sci; 2012 Sep; 13(6):560-9. PubMed ID: 22974090
[TBL] [Abstract][Full Text] [Related]
8. Triggers and mechanisms of skeletal muscle wasting in chronic obstructive pulmonary disease.
Langen RC; Gosker HR; Remels AH; Schols AM
Int J Biochem Cell Biol; 2013 Oct; 45(10):2245-56. PubMed ID: 23827718
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II inhibits satellite cell proliferation and prevents skeletal muscle regeneration.
Yoshida T; Galvez S; Tiwari S; Rezk BM; Semprun-Prieto L; Higashi Y; Sukhanov S; Yablonka-Reuveni Z; Delafontaine P
J Biol Chem; 2013 Aug; 288(33):23823-32. PubMed ID: 23831688
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II directly induces muscle protein catabolism through the ubiquitin-proteasome proteolytic pathway and may play a role in cancer cachexia.
Sanders PM; Russell ST; Tisdale MJ
Br J Cancer; 2005 Aug; 93(4):425-34. PubMed ID: 16052213
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II as candidate of cardiac cachexia.
Delafontaine P; Akao M
Curr Opin Clin Nutr Metab Care; 2006 May; 9(3):220-4. PubMed ID: 16607120
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-II-induced Muscle Wasting is Mediated by 25-Hydroxycholesterol via GSK3β Signaling Pathway.
Shen C; Zhou J; Wang X; Yu XY; Liang C; Liu B; Pan X; Zhao Q; Song JL; Wang J; Bao M; Wu C; Li Y; Song YH
EBioMedicine; 2017 Feb; 16():238-250. PubMed ID: 28161398
[TBL] [Abstract][Full Text] [Related]
13. Mas receptor: a potential strategy in the management of ischemic cardiovascular diseases.
Molaei A; Molaei E; Hayes AW; Karimi G
Cell Cycle; 2023 Jul; 22(13):1654-1674. PubMed ID: 37365840
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoid-induced skeletal muscle atrophy.
Schakman O; Kalista S; Barbé C; Loumaye A; Thissen JP
Int J Biochem Cell Biol; 2013 Oct; 45(10):2163-72. PubMed ID: 23806868
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II infusion induces marked diaphragmatic skeletal muscle atrophy.
Rezk BM; Yoshida T; Semprun-Prieto L; Higashi Y; Sukhanov S; Delafontaine P
PLoS One; 2012; 7(1):e30276. PubMed ID: 22276172
[TBL] [Abstract][Full Text] [Related]
16. Impact of the renin-angiotensin system on cardiac energy metabolism in heart failure.
Mori J; Zhang L; Oudit GY; Lopaschuk GD
J Mol Cell Cardiol; 2013 Oct; 63():98-106. PubMed ID: 23886814
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II suppresses autophagy and disrupts ultrastructural morphology and function of mitochondria in mouse skeletal muscle.
Silva KAS; Ghiarone T; Schreiber K; Grant D; White T; Frisard MI; Sukhanov S; Chandrasekar B; Delafontaine P; Yoshida T
J Appl Physiol (1985); 2019 Jun; 126(6):1550-1562. PubMed ID: 30946636
[TBL] [Abstract][Full Text] [Related]
18. The role of TGF-β signaling in muscle atrophy, sarcopenia and cancer cachexia.
Lan XQ; Deng CJ; Wang QQ; Zhao LM; Jiao BW; Xiang Y
Gen Comp Endocrinol; 2024 Jul; 353():114513. PubMed ID: 38604437
[TBL] [Abstract][Full Text] [Related]
19. Recent insights on the molecular mechanisms and therapeutic approaches for cardiac cachexia.
Martins T; Vitorino R; Moreira-Gonçalves D; Amado F; Duarte JA; Ferreira R
Clin Biochem; 2014 Jan; 47(1-2):8-15. PubMed ID: 24184665
[TBL] [Abstract][Full Text] [Related]
20. Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting.
Song YH; Li Y; Du J; Mitch WE; Rosenthal N; Delafontaine P
J Clin Invest; 2005 Feb; 115(2):451-8. PubMed ID: 15650772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
